Laboratory Corporation of America v. Patty Davis, etc. & Sheridan Radiology Services of Pinellas, Inc. v. Patty Davis, etc.

Supreme Court of Florida·Decided May 26, 2022·No. SC19-1923 & SC19-1936·Published

Opinion

Supreme Court of Florida

No. SC19-1923

LABORATORY CORPORATION OF AMERICA, et al., Petitioners,

vs.

PATTY DAVIS, etc., et al., Respondents.

No. SC19-1936

SHERIDAN RADIOLOGY SERVICES OF PINELLAS, INC., et al., Petitioners,

vs.

PATTY DAVIS, etc., et al., Respondents.

May 26, 2022

PER CURIAM.

In this case we consider the interaction between the statutory remedy for prohibited consumer debt collection practices provided

by the Florida Consumer Collection Practices Act (FCCPA) 1 and the provision of the Workers’ Compensation Law (WCL)2 vesting the Department of Financial Services (DFS) with exclusive jurisdiction to decide matters concerning workers’ compensation reimbursement. Before the Court for review is the decision of the Second District Court of Appeal in Davis v. Sheridan Healthcare, Inc., 281 So. 3d 1259 (Fla. 2d DCA 2019), in which the court held the WCL exclusive jurisdiction provision to be inapplicable as a bar to suit by an injured worker against a health care provider for prohibited debt collection practices. Id. at 1261. The Second District certified the following question to be of great public importance:

DOES SECTION 440.13(11)(c) OF THE WORKERS’

COMPENSATION LAW PRECLUDE CIRCUIT COURT JURISDICTION OVER CLAIMS UNDER SECTION 559.77(1) OF THE FLORIDA CONSUMER COLLECTION PRACTICES ACT?

Id. at 1267. We have jurisdiction. See art. V, § 3(b)(4), Fla. Const.

1. §§ 559.55-559.785, Fla. Stat. (2014).

2. Ch. 440, Fla. Stat. (2014).

We answer the certified question in the negative and approve the result reached by the Second District.

I

Patty Davis was injured during the course of her employment.

Subsequently, Davis utilized workers’ compensation benefits to receive medical care for her work-related injuries. Davis received medical care from two providers: Sheridan Radiology Services of Pinellas, Inc., a subsidiary of Sheridan Healthcare, Inc. (Sheridan); and Laboratory Corporation of America and Laboratory Corporation of America Holdings (Labcorp). Thereafter, Sheridan and Labcorp repeatedly billed Davis directly for the medical care that she received.

Davis then filed two separate actions against Sheridan and Labcorp under section 559.77(1), Florida Statutes (2014), of the FCCPA. Davis argued that as an injured employee under the WCL—chapter 440, Florida Statutes (2014)—she was not to be billed for seeking medical care for her work-related injuries. Instead, according to Davis’s claim, her employer’s workers’ compensation carrier, Commercial Risk Management, Inc. (CRM), was responsible for reimbursing Sheridan and Labcorp. In turn,

Davis maintained that Sheridan and Labcorp’s attempts to collect the debt from her constituted an attempt to collect an illegitimate debt, violating section 559.72, Florida Statutes (2014), of the FCCPA.

In response, Sheridan and Labcorp asserted that the trial courts lacked subject matter jurisdiction for the alleged FCCPA violations. Under Sheridan and Labcorp’s reasoning, section 440.13(11)(c) of the WCL unequivocally states that DFS “has exclusive jurisdiction to decide any matters concerning reimbursement.” Consequently, Sheridan and Labcorp claimed, because their billing Davis was merely a “matter[] concerning reimbursement,” exclusive jurisdiction over the matter was vested in DFS.

The trial courts agreed with Sheridan and Labcorp and dismissed Davis’s FCCPA claims. Davis appealed. In its consolidated opinion, the Second District held that “the WCL does not preclude Davis’s claims filed against her workers’ compensation medical providers under section 559.77(1) of the FCCPA,” reversed both trial court dismissals, and certified to this Court the question

of great public importance set forth above. Davis, 281 So. 3d at 1261, 1267.

II

Section 559.72 of the FCCPA prohibits various debt collection practices. Subsection (9) provides that “no person shall . . . [c]laim, attempt, or threaten to enforce a debt when such person knows that the debt is not legitimate, or assert the existence of some other legal right when such person knows that the right does not exist.” Section 559.77 contains provisions authorizing and governing civil remedies for violations of the FCCPA. Subsection (1) provides that “[a] debtor may bring a civil action against a person violating the provisions of s. 559.72.” Subsection (2) provides for the award of “actual damages and for additional statutory damages . . . not exceeding $1,000.” Punitive damages and other equitable relief are also authorized.

Section 440.13 of the WCL establishes the framework for the provision of medical services to injured workers and for the reimbursement of medical providers by carriers and employers for those services. Subsection (3)(g) provides that “[t]he employee is not liable for payment for medical treatment or services provided

pursuant to this section except as otherwise provided in this section.” In addition, subsection (13)(a) provides that “provider[s] may not collect or receive a fee from an injured employee within this state” unless otherwise provided and that “providers have recourse against the employer or carrier for payment for services rendered in accordance with [the WCL].” 3 Subsection (11)(a) of section 440.13 grants DFS the power to “investigate health care providers to determine whether providers are complying with [the WCL] and with rules adopted by [DFS],” including “whether the providers are engaging in overutilization,

3. Under subsection (5)(a) of section 440.13, an employee “requesting and selecting [an] independent medical examination shall be responsible for all expenses associated with said examination, including, but not limited to, medically necessary diagnostic testing performed and physician or medical care provider fees for the evaluation,” but “[i]f the employee prevails in a medical dispute as determined in an order by a judge of compensation claims or if benefits are paid or treatment provided after the employee has obtained an independent medical examination based upon the examiner’s findings, the costs of such examination shall be paid by the employer or carrier.” Subsection (5)(d) provides that an employee who without justification and proper notice fails to appear for an independent medical examination properly scheduled by a carrier or employer “shall reimburse the employer or carrier 50 percent of the physician’s cancellation or no-show fee.”

[and] whether providers are engaging in improper billing practices.” 4 “If [DFS] finds that a health care provider has improperly billed, overutilized, or failed to comply with [DFS] rules or the requirements of [the WCL]” DFS “may determine that the health care provider may not receive payment from the carrier or may impose penalties as set forth [elsewhere in the WCL].” If a provider has received improper payments “from a carrier,” the provider “must return those payments to the carrier.” DFS is authorized to impose “a penalty not to exceed $500” for overpayments that are not timely refunded.

Subsection (11)(c)—which is the focus of the issue presented by this case—provides that DFS “has exclusive jurisdiction to decide any matters concerning reimbursement, to resolve any overutilization dispute under subsection (7), and to decide any question concerning overutilization under subsection (8).” (Emphasis

4. Undergirding the authority of DFS regarding providers is the provision of subsection (3)(f) of section 440.13 that “[b]y accepting payment under [the WCL] for treatment rendered to an injured employee, a health care provider consents to the jurisdiction of [DFS] as set forth in subsection (11)” and to the submission of records relevant to “a reimbursement dispute, audit, or review.”

added.) The first mentioned subsection provides for remedies against carriers that improperly deny reimbursement, and the second subsection provides penalties against providers that engage in overutilization.

Free access — add to your briefcase to read the full text and ask questions with AI

Laboratory Corporation of America v. Patty Davis, etc. & Sheridan Radiology Services of Pinellas, Inc. v. Patty Davis, etc., (Fla. 2022).

Laboratory Corporation of America v. Patty Davis, etc. & Sheridan Radiology Services of Pinellas, Inc. v. Patty Davis, etc. (Laboratory Corporation of America v. Patty Davis, etc. & Sheridan Radiology Services of Pinellas, Inc. v. Patty Davis, etc.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Deal v. United States
508 U.S. 129 (Supreme Court, 1993)